Aspergillus & Aspergillosis,
… CD79B and/or MYD88 mutations, and 86% of evaluable patients achieved complete remission with DA-TEDDi-R. Increased…
… CD79B and/or MYD88 mutations, and 86% of evaluable patients achieved complete remission with DA-TEDDi-R. Increased…
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma! Research from National Institutes of Health (NIH…
RT @AspergillusWeb: Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma https://t.co/OERGAiMp6k
WT, wild-type. Figure 5 Association of Aspergillus with Ibrutinib (A) Aspergillus event time and dexamethasone exposure. Seven…